Oxycodone Hydrochloride And Acetaminophen
NDC 42549-640
Product Information
Oxycodone Hydrochloride And Acetaminophen is a ANDA-approved product labeled by Stat Rx Usa Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 42549-640 and 8 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
WHITE (C48325 - WHITE TO OFF-WHITE)
CAPSULE (C48336)
5 MM
IP203
IP204
1
Code Structure Chart
Product Details
What is NDC 42549-640?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OXYCODONE HYDROCHLORIDE (UNII: C1ENJ2TE6C)
- OXYCODONE (UNII: CD35PMG570) (Active Moiety)
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (UNII: 68401960MK)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONE (UNII: FZ989GH94E)
- STEARIC ACID (UNII: 4ELV7Z65AP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1049214 - oxyCODONE 10 MG / acetaminophen 325 MG Oral Tablet
- RxCUI: 1049214 - acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet
- RxCUI: 1049214 - APAP 325 MG / oxycodone hydrochloride 10 MG Oral Tablet
- RxCUI: 1049221 - oxyCODONE 5 MG / acetaminophen 325 MG Oral Tablet
- RxCUI: 1049221 - acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.